Menu

KKR, Constellation Energy On Deck Monday As Private Credit, Power Face Test

Benzinga Insights 2 hours ago

Earnings

KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX report before the

KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX report before the open; Occidental Petroleum, JBS, Skydance, Take-Two Interactive Software and Rocket Lab report after the close.

Key Reports Before The Bell

KKR (NYSE:KKR) — Q3 — 6:50 a.m. ET

  • EPS: $1.55 est. vs. $1.41 a year ago (+10%)
  • Revenue: $2.42 billion est. vs. $2.40 billion a year ago (+1%)
  • Stock: +6.1% past month, -24.3% YTD, 33.7% below its 52-week high
  • Analyst view: Buy consensus, $124 target (12 analysts)

KKR has beaten estimates in seven of its past eight quarters, but the focus is whether its fundraising engine and fee-related earnings can keep expanding while the stock remains well below its 52-week high. In Q2, it beat on both EPS and revenue. On its July call, management said KKR had delivered record fee-related earnings and adjusted net income while raising $305 billion since the start of 2024. BMO Capital maintained its Outperform rating while lowering its target to $109 from $118 in October.

Constellation Energy (NASDAQ:CEG) — Q3 — 7:00 a.m. ET

  • EPS: $3.88 est. vs. $3.04 a year ago (+28%)
  • Revenue: $9.22 billion est. vs. $6.57 billion a year ago (+40%)
  • Stock: -16.1% past month, -29.2% YTD, 34.3% below its 52-week high
  • Analyst view: Buy consensus, $340 target (11 analysts)

Constellation Energy has beaten estimates in six of its past eight quarters, with the key question being whether commercial and operational strength can support its nuclear-power growth story after a steep recent pullback. In Q2, it beat on EPS but missed revenue. On its August call, management raised its full-year adjusted operating earnings guidance range to $11.50 to $12.50 per share, citing strong commercial and operational performance. Morgan Stanley maintained its Overweight rating while raising its target to $391 from $378 in October.

Barrick Mining (NYSE:B) — Q3 — 6:00 a.m. ET

  • EPS: $0.78 est. vs. $0.58 a year ago (+34%)
  • Revenue: $5.12 billion est. vs. $4.15 billion a year ago (+23%)
  • Stock: -1.2% past month, -6.9% YTD, 25.7% below its 52-week high
  • Analyst view: Buy consensus, $51 target (10 analysts)

Barrick Mining has beaten estimates in four of its past eight quarters, making production execution and the economics of its North American gold-asset plans central to the report. In Q2, it missed on EPS but beat revenue. On its August call, management said a $4 billion agreement with Newmont resolved historical disputes and set the stage for a planned IPO of its North American gold assets. Freedom Broker downgraded the stock to Hold from Buy and lowered its target to $46 from $54 in October.

Ferguson Enterprises (NYSE:FERG) — Q3 — 6:45 a.m. ET

  • EPS: $3.29 est. vs. $2.50 a year ago (+32%)
  • Revenue: $8.70 billion est. vs. $7.62 billion a year ago (+14%)
  • Stock: +6.2% past month, +5.4% YTD, 14.0% below its 52-week high
  • Analyst view: Buy consensus, $289 target (10 analysts)

Ferguson Enterprises has beaten estimates in six of its past eight quarters, with investors watching whether organic growth and the FlowWorks acquisition can sustain the company’s operating momentum. In Q2, it beat on both EPS and revenue. On its August call, management highlighted organic sales growth, strong gross margin and the expected immediate earnings contribution from FlowWorks. Citigroup upgraded the stock to Buy from Neutral while raising its target to $288 from $285 in October.

ORIX (NYSE:IX) — Q2 — 6:00 a.m. ET

  • Stock: -5.7% past month, +19.3% YTD, 17.8% below its 52-week high

ORIX’s report will be read for the direction of its diversified financial businesses and whether its recent stock strength is supported by improving earnings visibility. In Q4, it beat the revenue estimate.

Key Reports After The Bell

Occidental Petroleum (NYSE:OXY) — Q3 — 4:15 p.m. ET

  • EPS: $1.46 est. vs. $0.64 a year ago (+128%)
  • Revenue: $6.86 billion est. vs. $6.72 billion a year ago (+2%)
  • Stock: -6.2% past month, +37.1% YTD, 15.9% below its 52-week high
  • Analyst view: Buy consensus, $72 target (13 analysts)

Occidental Petroleum has beaten estimates in all of its past eight quarters, leaving debt reduction, free-cash-flow improvement and capital returns as the main tests for another strong print. In Q2, it beat on both EPS and revenue. On its August call, management said principal debt had fallen to $11.8 billion, generating annualized interest savings of about $630 million, while the company remained on track for a $1.2 billion free-cash-flow improvement in 2026. Goldman Sachs maintained its Buy rating while raising its target to $76 from $69 in October.

JBS (NYSE:JBS) — Q3 — 8:43 p.m. ET

  • EPS: $0.94 est. vs. $0.52 a year ago (+81%)
  • Stock: -3.9% past month, -13.5% YTD, 33.1% below its 52-week high
  • Analyst view: Buy consensus, $18 target (4 analysts)

JBS has no reported eight-quarter beat record in the feed, so the focus is whether profitability can improve after a weak prior quarter and a sharp decline in the stock. In Q2, it missed on both EPS and revenue. On its August call, management reported $218 million in net income and $1.43 billion in adjusted EBITDA, with a 6% margin. Stephens & Co. maintained its Overweight rating while lowering its target to $17 from $18 in August.

Skydance (NYSE:SKYD) — Q3 — 4:00 p.m. ET

  • EPS: $0.18 est.
  • Revenue: $7.05 billion est.
  • Stock: -12.6% past month, -40.2% YTD, 18.2% below its 52-week high
  • Analyst view: Hold consensus, $8.60 target (5 analysts)

Skydance enters the report with the stock down sharply year to date, putting the emphasis on the pace of integration and whether the combined entertainment business can stabilize investor confidence. In Q2, it beat on both EPS and revenue. JPMorgan upgraded the stock to Neutral from Underweight and announced a $9 target in October.

Take-Two Interactive Software (NASDAQ:TTWO) — Q2 — 4:05 p.m. ET

  • EPS: -$0.59 est. vs. $1.46 a year ago (swing to loss)
  • Revenue: $1.66 billion est. vs. $1.96 billion a year ago (-15%)
  • Stock: +0.7% past month, -16.1% YTD, 18.8% below its 52-week high
  • Analyst view: Buy consensus, $293 target (13 analysts)

Take-Two Interactive Software has beaten estimates in seven of its past eight quarters, with investors focused on bookings momentum and the path toward the Grand Theft Auto 6 launch. In Q1, it beat on both EPS and revenue. On its August call, management said net bookings exceeded guidance because of strength in NBA 2K and the Grand Theft Auto series, while reaffirming its fiscal 2027 net bookings outlook. Macquarie started coverage at Outperform with a $300 target on Nov. 6.

Rocket Lab (NASDAQ:RKLB) — Q3 — 4:05 p.m. ET

  • EPS: -$0.06 est. vs. -$0.03 a year ago (wider loss)
  • Revenue: $257.0 million est. vs. $155.1 million a year ago (+66%)
  • Stock: -22.2% past month, -23.9% YTD, 64.5% below its 52-week high
  • Analyst view: Buy consensus, $103 target (13 analysts)

Rocket Lab has beaten estimates in just three of its past eight quarters, with the report testing whether launch demand and space-systems growth can regain traction after a steep stock decline. In Q2, it beat the revenue estimate. On its August call, management said record revenue was driven by demand across its launch and space-systems businesses and highlighted the planned Iridium acquisition. Citizens maintained its Market Outperform rating while lowering its target to $90 from $130 in October.

Also Reporting Before The Bell

  • Roivant Sciences (NASDAQ:ROIV) — -$0.46 EPS on $3.8 million revenue
  • RB Global (NYSE:RBA) — $0.98 EPS on $1.17 billion revenue
  • Kaspi.kz JSC (NASDAQ:KSPI) — $3.12 EPS on $2.65 billion revenue
  • NRG Energy (NYSE:NRG) — $3.11 EPS on $8.78 billion revenue
  • Somnigroup International (NYSE:SGI) — $1.05 EPS on $2.42 billion revenue
  • CNH Industrial (NYSE:CNH) — $0.10 EPS on $4.51 billion revenue
  • Affiliated Managers Group (NYSE:AMG) — $8.77 EPS on $649.2 million revenue
  • TG Therapeutics (NASDAQ:TGTX) — $0.28 EPS on $245.8 million revenue
  • Praxis Precision Medicines (NASDAQ:PRAX) — -$3.64 EPS on $485,000 revenue
  • Ionis Pharmaceuticals (NASDAQ:IONS) — -$0.99 EPS on $183.3 million revenue
  • RadNet (NASDAQ:RDNT) — $0.22 EPS on $638.9 million revenue
  • Immunovant (NASDAQ:IMVT) — -$0.72 EPS

Technology: Monday.Com (MNDY) and Via Transportation (VIA).

Energy: Kodiak Gas Services (KGS) and Select Water Solutions (WTTR).

Also on the calendar: Fervo Energy (FRVO).

Plus 32 companies valued between $100 million and $2 billion, including National Energy Services Reunited, Ocular Therapeutix and Global Ship Lease.

Also Reporting After The Bell

  • Credicorp (NYSE:BAP) — $7.51 EPS on $1.84 billion revenue
  • Grupo Cibest (NYSE:CIB) — $2.87 EPS on $2.20 billion revenue
  • Equinox Gold (AMEX:EQX) — $0.18 EPS on $1.03 billion revenue
  • Onto Innovation (NYSE:ONTO) — $2.30 EPS on $391.8 million revenue
  • AST SpaceMobile (NASDAQ:ASTS) — -$0.44 EPS on $45.7 million revenue
  • Lineage (NASDAQ:LINE) — $0.58 EPS on $1.36 billion revenue
  • TIM (NYSE:TIMB) — $0.43 EPS on $1.37 billion revenue
  • Zeta Global Holdings (NYSE:ZETA) — $0.23 EPS on $471.0 million revenue
  • Qualys (NASDAQ:QLYS) — $1.86 EPS on $186.6 million revenue
  • Clearway Energy (NYSE:CWEN) — $1.80 EPS on $513.3 million revenue
  • Sanmina (NASDAQ:SANM) — $3.19 EPS on $3.48 billion revenue
  • H&R Block (NYSE:HRB) — -$1.44 EPS on $212.1 million revenue

Health care: Hims & Hers Health (HIMS), Definium Therapeutics (DFTX), Xenon Pharmaceuticals (XENE), AbCellera Biologics (ABCL) and Zymeworks (ZYME).

Industrials: Casella Waste Systems (CWST), AAON (AAON), EquipmentShare.com (EQPT) and Archer Aviation (ACHR).

Technology: Novanta (NOVT), Life360 (LIF), Csquare (CSQR) and MARA Holdings (MARA).

Energy: NexGen Energy (NXE), Tidewater (TDW) and DHT Holdings (DHT).

Financials: Intercorp Financial Services (IFS), Kemper (KMPR) and Goosehead Insurance (GSHD).

Also on the calendar: Trade Desk (TTD), National Health Investors (NHI) and USA Rare Earth (USAR).

Plus 67 companies valued between $100 million and $2 billion, including GeneDx Holdings, Plug Power and Trevi Therapeutics.

Timing to be confirmed: Turkcell Iletisim Hizmetleri AS (TKC) and Greenfire Resources (GFR).

See the full Benzinga earnings calendar

Read the original